SCN2A mutation C258R causes DEE type 11

Köppel, A., H. de Vries, M. Jamili, U. Brandl, E. Leipold, S.H. Heinemann (2026) Functional and pharmacological characterization of the SCN2A variant p.C258R with mixed gain- and loss-of-function causing developmental and epileptic encephalopathy type 11. Epilepsy & Behavior Reports 36 100897. PMID: 42774767.

SCN2A p.C258R

C258R mutation in SCN2A

C258R mutation in SCN2A

Illustration: FSU Biophysik

Pathogenic variants in SCN2A cause dysfunction of the NaV1.2 voltage-gated sodium channel and are associated with neurodevelopmental disorders with or without epilepsy. We describe a patient with the de novo SCN2A variant p.C258R presenting with therapy-resistant developmental and epileptic encephalopathy type 11 (DEE type 11). We characterized the functional effects of this mutation after heterologous expression in HEK293T cells. Depending on the specific functional readout, mutation C258R of NaV1.2 channels resulted in a mixed LoF and GoF phenotype. NaV1.2-C258R channels exhibited slower inactivation kinetics and a left-shifted voltage dependence of steady-state inactivation. The slowed fast inactivation likely underlies seizure susceptibility. Sodium channel blockers with a strong use-dependence, such as phenytoin, may be preferential for seizure control in such cases.